LexDanaLexDanabeta
Inventor

Sylvie FROIDEVAUX

Inventor
CH

Overview

3→
Patents
2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes17%
PatentTitleYear
11,739,070C5A receptor modulators202311,685,729C5a receptor modulators202311,608,341Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to IDORSIA PHARMACEUTICALS LTD (3)· patent assignee history
2023Based in CH· patent location history
2023Based in SE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IDORSIA PHARMACEUTICALS LTD32023
Locations
LocationPatentsSpan
CH22023
SE12023